Skip to main content
SpringerLink
Log in

Relationship between Organizational Culture and the Use of Psychotropic Medicines in Nursing Homes: A Systematic Integrative Review

  • Systematic Review
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Background

Psychotropic medicines are commonly used in nursing homes, despite marginal clinical benefits and association with harm in the elderly. Organizational culture is proposed as a factor explaining the high-level use of psychotropic medicines. Schein describes three levels of culture: artifacts, espoused values, and basic assumptions.

Objective

This integrative review aimed to investigate the facets and role of organizational culture in the use of psychotropic medicines in nursing homes.

Method

Five databases were searched for qualitative, quantitative, and mixed method empirical studies up to 13 February 2017. Articles were included if they examined an aspect of organizational culture according to Schein’s theory and the use of psychotropic medicines in nursing homes for the management of behavioral and sleep disturbances in residents. Article screening and data extraction were performed independently by one reviewer and checked by the research team. The integrative review method, an approach similar to the method of constant comparison analysis was utilized for data analysis.

Results

Twenty-four studies met the inclusion criteria: 13 used quantitative methods, 9 used qualitative methods, 1 was quasi-qualitative, and 1 used mixed methods. Included studies were found to only address two aspects of organizational culture in relation to the use of psychotropic medicines: artifacts and espoused values. No studies addressed the basic assumptions, the unsaid taken-for-granted beliefs, which provide explanations for in/consistencies between the ideal use of psychotropic medicines and the actual use of psychotropic medicines.

Conclusions

Previous studies suggest that organizational culture influences the use of psychotropic medicines in nursing homes; however, what is known is descriptive of culture only at the surface level, that is the artifacts and espoused values. Hence, future research that explains the impact of the basic assumptions of culture on the use of psychotropic medicines is important.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Seitz DP, Gill SS, Herrmann N, Brisbin S, Rapoport MJ, Rines J, et al. Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review. Int Psychogeriatr. 2013;25(2):185–203.

    Article  PubMed  Google Scholar 

  2. Maher AR, Maglione M, Bagley S, Suttorp M, Hu J-H, Ewing B, et al. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis. JAMA. 2011;306(12):1359–69.

    Article  CAS  PubMed  Google Scholar 

  3. Bourgeois J, Elseviers MM, Bortel LV, Petrovic M, Vander Stichele RH. Sleep quality of benzodiazepine users in nursing homes: a comparative study with nonusers. Sleep Med. 2013;14(7):614–21.

    Article  PubMed  Google Scholar 

  4. Ballard C, Waite J. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. Cochrane Database Syst Rev. 2006;25(1):CD003476.

    Google Scholar 

  5. Olazarán J, Valle D, Serra JA, Cano P, Muñiz R. Psychotropic medications and falls in nursing homes: a cross-sectional study. J Am Med Dir Assoc. 2013;14(3):213–7.

    Article  PubMed  Google Scholar 

  6. Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA. 2005;294(15):1934–43.

    Article  CAS  PubMed  Google Scholar 

  7. Aparasu RR, Chatterjee S, Chen H. Risk of pneumonia in elderly nursing home residents using typical versus atypical antipsychotics. Ann Pharmacother. 2013;47(4):464–74.

    Article  PubMed  Google Scholar 

  8. Snowdon J, Galanos D, Vaswani D. Patterns of psychotropic medication use in nursing homes: surveys in Sydney, allowing comparisons over time and between countries. Int Psychogeriatr. 2011;23(9):1520–5.

    Article  PubMed  Google Scholar 

  9. Simoni-Wastila L, Wei YJ, Luong M, Franey C, Huang TY, Rattinger GB, et al. Quality of psychopharmacological medication use in nursing home residents. Res Soc Adm Pharm. 2014;10(3):494–507.

    Article  Google Scholar 

  10. Chen Y, Briesacher BA, Field TS, Tjia J, Lau DT, Gurwitz JH. Unexplained variation across US nursing homes in antipsychotic prescribing rates. Arch Intern Med. 2010;170(1):89–95.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Huybrechts KF, Rothman KJ, Brookhart MA, Silliman RA, Crystal S, Gerhard T, et al. Variation in antipsychotic treatment choice across US nursing homes. J Clin Psychopharmacol. 2012;32(1):11–7.

    Article  PubMed  Google Scholar 

  12. Kamble P, Chen H, Sherer J, Aparasu RR. Antipsychotic drug use among elderly nursing home residents in the United States. Am J Geriatr Pharmacother. 2008;6(4):187–97.

    Article  PubMed  Google Scholar 

  13. Svarstad BL, Mount JK. Chronic benzodiazepine use in nursing homes: effects of federal guidelines, resident mix, and nurse staffing. J Am Geriatr Soc. 2001;49(12):1673–8.

    Article  CAS  PubMed  Google Scholar 

  14. Hughes CM, Lapane KL, Mor V. Influence of facility characteristics on use of antipsychotic medications in nursing homes. Med Care. 2000;38(12):1164–73.

    Article  CAS  PubMed  Google Scholar 

  15. Rochon PA, Stukel TA, Bronskill SE, Gomes T, Sykora K, Wodchis WP, et al. Variation in nursing home antipsychotic prescribing rates. Arch Intern Med. 2007;167(7):676–83.

    Article  PubMed  Google Scholar 

  16. Zuidema SU, de Jonghe JF, Verhey FR, Koopmans RT. Psychotropic drug prescription in nursing home patients with dementia: influence of environmental correlates and staff distress on physicians’ prescription behavior. Int Psychogeriatr. 2011;23(10):1632–9.

    Article  PubMed  Google Scholar 

  17. Cody M, Beck C, Svarstad BL. Challenges to the use of nonpharmacologic interventions in nursing homes. Psychiatr Serv. 2002;53(11):1402–6.

    Article  PubMed  Google Scholar 

  18. Schmidt I, Claesson CB, Westerholm B, Nilsson LG, Svarstad BL. The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes. J Am Geriatr Soc. 1998;46(1):77–82.

    Article  CAS  PubMed  Google Scholar 

  19. Alldred DP, Zermansky AG, Petty DR, Raynor DK, Freemantle N, Eastaugh J, et al. Clinical medication review by a pharmacist of elderly people living in care homes: pharmacist interventions. Int J Pharm Pract. 2007;15(2):93–9.

    Article  Google Scholar 

  20. Thompson Coon J, Abbott R, Rogers M, Whear R, Pearson S, Lang I, et al. Interventions to reduce inappropriate prescribing of antipsychotic medications in people with dementia resident in care homes: a systematic review. J Am Med Dir Assoc. 2014;15(10):706–18.

    Article  PubMed  Google Scholar 

  21. Li J, Porock D. Resident outcomes of person-centered care in long-term care: a narrative review of interventional research. Int J Nurs Stud. 2014;51(10):1395–415.

    Article  PubMed  Google Scholar 

  22. Nishtala PS, McLachlan AJ, Bell JS, Chen TF. Psychotropic prescribing in long-term care facilities: impact of medication reviews and educational interventions. Am J Geriatr Psychiatry. 2008;16(8):621–32.

    Article  PubMed  Google Scholar 

  23. Scott T, Mannion R, Davies H, Marshall M. The quantitative measurement of organizational culture in health care: a review of the available instruments. Health Serv Res. 2003;38(3):923–45.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Davies HT, Nutley SM, Mannion R. Organisational culture and quality of health care. Qual Health Care. 2000;9(2):111–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Scott T, Mannion R, Davies HT, Marshall MN. Implementing culture change in health care: theory and practice. Int J Qual Health Care. 2003;15(2):111–8.

    Article  PubMed  Google Scholar 

  26. Davies H, Mannion R, Jacobs R, Powell A, Marshall M. Exploring the relationship between senior management team culture and hospital performance. Med Care Res Rev. 2007;64(1):46–65.

    Article  CAS  PubMed  Google Scholar 

  27. Hughes CM, Lapane K, Watson MC, Davies HTO. Does organisational culture influence prescribing in care homes for older people? A new direction for research. Drugs Aging. 2007;24(2):81–93.

    Article  PubMed  Google Scholar 

  28. Scott T, Mannion R, Marshall M, Davies H. Does organisational culture influence health care performance? A review of the evidence. J Health Serv Res Policy. 2003;8(2):105–17.

    Article  PubMed  Google Scholar 

  29. Schein EH. Organizational culture and leadership. 4th ed. San Francisco, CA: Jossey-Bass; 2010.

    Google Scholar 

  30. Schein EH. Coming to a new awareness of organizational culture. Sloan Manag Rev. 1984;25(2):3–16.

    Google Scholar 

  31. Schein EH. Sense and nonsense about culture and climate. In: Ashkanasy NM, Wilderom CPM, Peterson MF, editors. Handbook of organizational culture & climate. Thousand Oaks: Sage; 2000. p. xxiii–xxx.

    Google Scholar 

  32. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Whittemore R, Knafl K. The integrative review: updated methodology. J Adv Nurs. 2005;52(5):546–53.

    Article  PubMed  Google Scholar 

  34. Dixon-Woods M, Fitzpatrick R, Roberts K. Including qualitative research in systematic reviews: opportunities and problems. J Eval Clin Pract. 2001;7(2):125–33.

    Article  CAS  PubMed  Google Scholar 

  35. Stowasser DA, Allinson YM, O’Leary M. Understanding the medicines management pathway. J Pharm Pract Res. 2004;34(4):293–6.

    Article  Google Scholar 

  36. Cohen-Mansfield J, Jensen B. Physicians’ perceptions of their role in treating dementia-related behavior problems in the nursing home: actual practice and the ideal. J Am Med Dir Assoc. 2008;9(8):552–7.

    Article  PubMed  Google Scholar 

  37. Cohen-Mansfield J, Jensen B. Nursing home physicians’ knowledge of and attitudes toward nonpharmacological interventions for treatment of behavioral disturbances associated with dementia. J Am Med Dir Assoc. 2008;9(7):491–8.

    Article  PubMed  Google Scholar 

  38. Cohen-Mansfield J, Jensen B. Assessment and treatment approaches for behavioral disturbances associated with dementia in the nursing home: self-reports of physicians’ practices. J Am Med Dir Assoc. 2008;9(6):406–13.

    Article  PubMed  Google Scholar 

  39. Sawan M, Jeon YH, Fois RA, Chen TF. Exploring the link between organizational climate and the use of psychotropic medicines in nursing homes: a qualitative study. Res Social Adm Pharm. 2017;13(3):513–23.

    Article  PubMed  Google Scholar 

  40. Sawan MJ, Jeon YH, Fois RJ, Chen TF. A qualitative study exploring visible components of organizational culture: what influences the use of psychotropic medicines in nursing homes? Int Psychogeriatr. 2016;28(10):1725–35.

    Article  PubMed  Google Scholar 

  41. Ellis ML, Molinari V, Dobbs D, Smith K, Hyer K. Assessing approaches and barriers to reduce antipsychotic drug use in Florida nursing homes. Aging Mental Health. 2015;19(6):507–16.

    Article  PubMed  Google Scholar 

  42. Lemay CA, Mazor KM, Field TS, Donovan J, Kanaan A, Briesacher BA, et al. Knowledge of and perceived need for evidence-based education about antipsychotic medications among nursing home leadership and staff. J Am Med Dir Assoc. 2013;14(12):895–900.

    Article  PubMed  Google Scholar 

  43. Mort JR, Singh YN, Gaspar PM, Adams PL, Singh NN. Attitudes and knowledge of long term care nurses toward psychotropic medication for the elderly. Clin Gerontol. 1993;12(3):13–31.

    Article  Google Scholar 

  44. Svarstad BL, Mount JK, Bigelow W. Variations in the treatment culture of nursing homes and responses to regulations to reduce drug use. Psychiatr Serv. 2001;52(5):666–72.

    Article  CAS  PubMed  Google Scholar 

  45. Thurmond JA. Nurses’ perceptions of chemical restraint use in long-term care. Appl Nurs Res. 1999;12(3):159–62.

    Article  CAS  PubMed  Google Scholar 

  46. Ervin K, Finlayson S, Cross M. The management of behavioural problems associated with dementia in rural aged care. Collegian. 2012;19(2):85–95.

    Article  PubMed  Google Scholar 

  47. Smith MA, Simpson JM, Benrimoj SI. General practitioner acceptance of medication review in Sydney nursing homes. J Pharm Pract Res. 2002;32(3):227–31.

    Article  Google Scholar 

  48. Hughes CM, Goldie R. “I just take what i am given” adherence and resident involvement in decision making on medicines in nursing homes for older people: a qualitative survey. Drugs Aging. 2009;26(6):505–17.

    Article  PubMed  Google Scholar 

  49. Patterson SM, Hughes CM, Lapane KL. Assessment of a United States pharmaceutical care model for nursing homes in the United Kingdom. Pharm World Sci. 2007;29(5):517–25.

    Article  PubMed  Google Scholar 

  50. Shaw C, McCormack B, Hughes CM. Prescribing of psychoactive drugs for older people in nursing homes: an analysis of treatment culture. Drugs Real World Outcomes. 2016;3(1):121–3.

    Article  PubMed Central  Google Scholar 

  51. Wood-Mitchell A, James IA, Waterworth A, Swann A, Ballard C. Factors influencing the prescribing of medications by old age psychiatrists for behavioural and psychological symptoms of dementia: a qualitative study. Age Ageing. 2008;37(5):547–52.

    Article  PubMed  Google Scholar 

  52. Cornege-Blokland E, Kleijer BC, Hertogh CM, van Marum RJ. Reasons to prescribe antipsychotics for the behavioral symptoms of dementia: a survey in Dutch nursing homes among physicians, nurses, and family caregivers. J Am Med Dir Assoc. 2012;13(1):80.e1–6.

    Article  PubMed  Google Scholar 

  53. Janus SIM, van Manen JG, Ijzerman MJ, Bisseling M, Drossaert CHC, Zuidema SU. Determinants of the nurses’ and nursing assistants’ request for antipsychotics for people with dementia. Int Psychogeriatr. 2017;29(3):475–84.

    Article  PubMed  Google Scholar 

  54. Smeets CHW, Smalbrugge M, Zuidema SU, Derksen E, de Vries E, van der Spek K, et al. Factors related to psychotropic drug prescription for neuropsychiatric symptoms in nursing home residents with dementia. J Am Med Dir Assoc. 2014;15(11):835–40.

    Article  PubMed  Google Scholar 

  55. Anthierens S, Grypdonck M, De Pauw L, Christiaens T. Perceptions of nurses in nursing homes on the usage of benzodiazepines. J Clin Nurs. 2009;18(22):3098–106.

    Article  PubMed  Google Scholar 

  56. Azermai M, Vander Stichele RR, Van Bortel LM, Elseviers MM. Barriers to antipsychotic discontinuation in nursing homes: an exploratory study. Aging Mental Health. 2014;18(3):346–53.

    Article  PubMed  Google Scholar 

  57. Bourgeois J, Elseviers MM, Azermai M, Van Bortel L, Petrovic M, Vander Stichele RR. Barriers to discontinuation of chronic benzodiazepine use in nursing home residents: perceptions of general practitioners and nurses. Eur Geriatr Med. 2014;5(3):181–7.

    Article  Google Scholar 

  58. Flick U, Garms-Homolova V, Rohnsch G. “And mostly they have a need for sleeping pills”: Physicians’ views on treatment of sleep disorders with drugs in nursing homes. J Aging Stud. 2012;26(4):484–94.

    Article  PubMed  Google Scholar 

  59. Lhermite A, Munoz Sastre MT, Sorum PC, Mullet E. French lay people’s and health professionals’ views regarding the acceptability of involuntary treatment of nursing home residents. Int J Law Psychiatry. 2015;38:38–43.

    Article  PubMed  Google Scholar 

  60. Pekkarinen L, Elovainio M, Sinervo T, Finne-Soveri H, Noro A. Nursing working conditions in relation to restraint practices in long-term care units. Med Care. 2006;44(12):1114–20.

    Article  PubMed  Google Scholar 

  61. Peri K, Kerse N, Moyes S, Scahill S, Chen C, Hong JB, et al. Is psychotropic medication use related to organisational and treatment culture in residential care. J Health Organ Manag. 2015;29(7):1065–79.

    Article  PubMed  Google Scholar 

  62. Schmid IK, Svarstad BL. Nurse-physician communication and quality of drug use in Swedish nursing homes. Soc Sci Med. 2002;54(12):1767–77.

    Article  Google Scholar 

  63. Hughes CM, Roughead E, Kerse N. Improving use of medicines for older people in long-term care: contrasting the policy approach of four countries. Healthc Policy. 2008;3(3):e154–67.

    PubMed  PubMed Central  Google Scholar 

  64. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.

    Article  Google Scholar 

  65. Sexton JB, Helmreich RL, Neilands TB, Rowan K, Vella K, Boyden J, et al. The Safety Attitudes Questionnaire: psychometric properties, benchmarking data, and emerging research. BMC Health Serv Res. 2006;6(1):44.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Stein-Parbury J, Chenoweth L, Jeon YH, Brodaty H, Haas M, Norman R. Implementing person-centered care in residential dementia care. Clin Gerontol. 2012;35(5):404–24.

    Article  Google Scholar 

  67. Beer C, Horner B, Almeida OP, Scherer S, Lautenschlager NT, Bretland N, et al. Current experiences and educational preferences of general practitioners and staff caring for people with dementia living in residential facilities. BMC Geriatr. 2009;9(1):1–8.

    Article  Google Scholar 

  68. Scott-Cawiezell J, Jones K, Moore L, Vojir C. Nursing home culture: a critical component in sustained improvement. J Nurs Care Qual. 2005;20(4):341–8.

    Article  PubMed  Google Scholar 

  69. Nishtala PS, Hilmer SN, McLachlan AJ, Hannan PJ, Chen TF. Impact of residential medication management reviews on drug burden index in aged-care homes: a retrospective analysis. Drugs Aging. 2009;26(8):677–86.

    Article  PubMed  Google Scholar 

  70. Ballard C, Corbett A. Management of neuropsychiatric symptoms in people with dementia. CNS Drugs. 2010;24(9):729–39.

    PubMed  Google Scholar 

  71. Verrue CL, Petrovic M, Mehuys E, Remon JP, Vander Stichele R. Pharmacists’ interventions for optimization of medication use in nursing homes: a systematic review. Drugs Aging. 2009;26(1):37–49.

    Article  PubMed  Google Scholar 

  72. Aiken LH, Cimiotti JP, Sloane DM, Smith HL, Flynn L, Neff DF. Effects of nurse staffing and nurse education on patient deaths in hospitals with different nurse work environments. Med Care. 2011;49(12):1047–53.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Estabrooks CA, Midodzi WK, Cummings GG, Ricker KL, Giovannetti P. The impact of hospital nursing characteristics on 30-day mortality. J Nurs Adm. 2011;41(7–8 Suppl):S58–68.

    Article  PubMed  Google Scholar 

  74. Hewison A. Organizational culture: a useful concept for nurse managers? J Nurs Manag. 1996;4(1):3–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Pharmacy, The University of Sydney, N507, Pharmacy and Bank Building (A15), Camperdown, NSW, 2006, Australia

    Mouna Sawan & Timothy F. Chen

  2. Faculty of Nursing and Midwifery, The University of Sydney, M02A, 88 Mallett Street, Building A, Camperdown, NSW, 2006, Australia

    Yun-Hee Jeon

Authors
  1. Mouna Sawan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yun-Hee Jeon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Timothy F. Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the study concept and design, analysis and interpretation of data, and preparation of the manuscript.

Corresponding author

Correspondence to Mouna Sawan.

Ethics declarations

Conflict of interest

Mouna J. Sawan, Yun-Hee Jeon, and Timothy F. Chen have no financial or other personal conflicts with this paper.

Funding

The authors received no financial support or grants for the research, authorship, and/or publication of this article.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 14 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sawan, M., Jeon, YH. & Chen, T.F. Relationship between Organizational Culture and the Use of Psychotropic Medicines in Nursing Homes: A Systematic Integrative Review. Drugs Aging 35, 189–211 (2018). https://doi.org/10.1007/s40266-018-0527-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40266-018-0527-5

Search

Navigation